The largest-ever study on medical cannabis for cancer: The results revealed

Every 90 seconds, another UK receives a diagnosis that changes everything. Cancer, a condition that slams the handbrake on any plans, quickly reshapes futures, and ripples through families and communities with quiet but devastating force.

Slightly more than a quarter of all deaths in the country each year trace back to it. One in three of us will feel its presence, either personally or through someone close. There is simply no way around it - cancer is an issue that touches almost every life, whether out of the blue or by slow invasion. 

And while treatment options have advanced (especially in the past 10 years), the reality for many remains the same: managing the condition is as much about navigating the side effects of the current treatment options as it is about fighting the illness/symptoms itself.

What are the common secondary symptoms of cancer?

Secondary symptoms of cancer include pain that doesn’t let up, nausea that makes even room-temperature water feel like a risk, appetite that vanishes overnight, and finding a truly restful sleep often feels impossible (usually when it’s needed most). 

And it’s not just the physical symptoms that add to the already overwhelming burden and fear of the unknowable. The mental load sneaks in, too. 

Rates of both anxiety and depression are notably higher among people living with or recovering from cancer. It's no wonder, really. The uncertainty, the disruption, the huge and unexpected changes in day-to-day life, the sheer relentlessness of it all  - it wears people down in ways that don’t always show up on a scan. 

And so, many begin to look beyond the standard toolkit. Not in search of false hope, but for something that might help with the secondary issues. Medical cannabis, for far too long simply dismissed outright, is now a rapidly growing part of that conversation. Not as a replacement for treatment, but as a way to manage the effects of it.

What’s been missing, until recently, is clarity.

That changed with a new study (the largest of its kind, released by the World Health Oncology Institute in Colorado) that pulled together more than 10,000 pieces of research to ask a straightforward question: 

“Is there genuine scientific support for the application of medical cannabis as part of a holistic cancer treatment plan?”

Why people are turning to medical cannabis during cancer care

It should come as no surprise that people battling all types of cancer look beyond conventional treatment options. Pain, appetite loss, nausea, poor sleep, mental health concerns - these aren’t just symptoms or side effects, they’re life-altering realities. 

And these just happen to be issues that medical cannabis has been shown, time and again, to be able to help with. Not for every single patient, but often enough, and with enough consistency, that the question is no longer “should we be exploring this?”, but “why haven’t we been all along?”.

Well, to a certain respect we have. But a recent study has finally pulled all the currently available data all together. Published two weeks ago in Frontiers in Oncology, “Meta-analysis of medical cannabis outcomes and associations with cancer” is  the largest of its kind - a meta-analysis of over 10,000 peer-reviewed papers looking at medical cannabis and its role in cancer care.

The aim wasn’t to prove a point. It was to map the current landscape, to take in the full breadth of research and ask (and answer) a simple question: 

“Where does the evidence on medical cannabis for cancer patients actually point?”

What 10,641 studies reveal about cannabis and cancer

The researchers didn’t cherry-pick. They ran a sentiment analysis across 39,767 data points - an AI-powered core drill into how the scientific literature really views medical cannabis in cancer contexts.

And the findings were more decisive than many expected:

• Around 65% of studies leaned in favour of cannabis use for cancer care
• Just over 30% expressed doubt or opposition
• The rest landed somewhere in between

Where was the strongest support?

Cannabis supported symptom management: consistent, patient-reported benefits

Medical cannabis offered better outcomes for cancer patients dealing with:

• Pain - especially for neuropathic and chronic cancer-related pain
• Nausea and vomiting - particularly linked to chemotherapy, showed marked improvement in study after study
• Appetite issues - Hunger stimulation was another common positive, offering real support to those facing weight loss and food aversion
• A marked drop in sleep quality and duration - sleep quality improved for many, with patients reporting deeper rest and fewer nighttime interruptions.
• Anxiety and low mood/depression - medical cannabis also showed amazing potential to bring emotional relief.
  
  

Anti-inflammatory properties of medical cannabis: a well-established pathway

• Medical cannabis was repeatedly shown to reduce inflammation markers, which is significant given inflammation’s role in tumour development and overall disease burden.

• The anti-inflammatory effects were some of the most robustly supported outcomes in the entire meta-analysis.

• Very few studies showed contradictory findings in this area, suggesting a strong degree of consensus.
  
  

Preclinical evidence for the potential antitumour activity of medical cannabis

In cell and animal studies, cannabinoids (like THC and CBD) were associated with:

• Apoptosis (programmed death of cancer cells)
• Reduced tumour size and slowed tumour growth
• Inhibited spread of cancerous cells (metastasis)
  
  

While these results are yet to be displayed and confirmed through human trials, (and therefore medical cannabis is not prescribed to treat cancer itself, and instead it's prescribed to treat secondary symptoms) they were consistently supported across multiple models and cancer types.

Palliative care integration of medical cannabis 

• Cannabis was widely supported as a complementary therapy, but not a substitute for conventional cancer treatment.
• It was especially useful in cases where patients had exhausted standard symptom management options.
• The review suggested that cannabis can enhance quality of life without major safety concerns, especially when monitored by specialists.

Supporting patients with medical cannabis when other tools fall short

Many studies recommended that medical cannabis may be an effective option within the wider toolkit of cancer care (when applied as one part of a holistic treatment plan), and especially when symptoms proved difficult to manage through conventional treatment options.

• It should not be seen or promoted as a replacement for conventional cancer treatment, but a companion to it.
• The benefits were most obvious when other treatment options had failed, or caused heavy side effects.
• In those cases, medical cannabis offered meaningful relief where other options had failed. For patients in palliative care, that carries real weight.

What UK medical cannabis clinics are allowed to say (and what they’re not) regarding cancer treatment

Despite the flurry of headlines, medical cannabis clinics in the UK (like us here at Releaf) are legally barred from claiming that medical cannabis can treat or cure cancer. The aim is not to hold back progress, but to make sure patients are given treatments backed by solid, trusted evidence -  and these regulations are in place for good reason. 

The MHRA, ASA, and GMC all maintain strict boundaries on what clinics can say publicly:

• No treatment claims can be made for unlicensed medicines (which include nearly all cannabis products in the UK)
• Patient testimonials that suggest tumour shrinkage, remission, or cancer control are not permitted
• Any reference to scientific research must present a full and balanced view and must not imply that cannabis can replace standard cancer treatments

What clinics can say is that medical cannabis has shown potential to support the management of symptoms often experienced during cancer care. These include:

• Persistent or neuropathic pain
• Chemotherapy-induced nausea and vomiting
• Appetite loss and weight changes
• Anxiety, insomnia, and reduced quality of life

In short, medical cannabis can be prescribed in the UK to support patients living with cancer. It cannot replace oncology. And no responsible UK medical cannabis clinic will ever suggest otherwise.

Where does this landmark review leave medical cannabis for cancer treatment in the UK? 

The Castle study doesn’t offer a cure. It offers clarity. It tells us that most of the scientific community agrees on this: medical cannabis has obvious potential in cancer care. Not just as a way to reduce suffering, but perhaps, one day, as something more.

Still, we need research papers that go beyond the petri dish. We need many, many more clinical studies with human participants that pit cannabis-based treatment options against a placebo. 

And we need to be honest about what we know and what we don’t. Because until those trials are run, medical cannabis in the UK will (quite rightly) remain focused on helping people feel better, not getting ahead of the evidence.

How can I access medical cannabis for cancer support?

If you’re living with cancer and curious about whether cannabis might support your symptom management, we’re here to talk. Releaf’s world-class clinical team offers expert, individualised care. 

Our resident oncology specialist (and also Releaf’s Medical Director), Dr Sue Clenton, had this to say: 

"The burden of cancer is often quite broad, and treatments bring their own struggles. We are already helping patients living with cancer to feel better in themselves and manage their symptoms more effectively. With better mood and sleep, less pain, and improvements in other symptoms such as appetite, patients feel more able to tolerate treatment and focus on what matters most - living their lives."

If you are ready to find out more about medical cannabis for cancer in the UK, and wondering whether this path might be right for you (or a loved one), Releaf is here to help. Head to our fast, free medical cannabis eligibility checker - it takes less than 20 seconds to complete, and you’ll get instant feedback on whether you will be suitable for a legal UK medical cannabis prescription.ca